Spironolactone Ceva

RSS

Withdrawn

This medicine's authorisation has been withdrawn

spironolactone
MedicineVeterinaryWithdrawn

Irish is available via eTranslation, the European Commission's machine translation service.

Translate to Irish | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for this product has been withdrawn due to the application of the sunset clause.

български (BG) (332.91 KB - PDF)

Amharc

español (ES) (288.28 KB - PDF)

Amharc

čeština (CS) (322.23 KB - PDF)

Amharc

dansk (DA) (287.53 KB - PDF)

Amharc

Deutsch (DE) (289.53 KB - PDF)

Amharc

eesti (ET) (276.29 KB - PDF)

Amharc

ελληνικά (EL) (335.21 KB - PDF)

Amharc

français (FR) (289.25 KB - PDF)

Amharc

hrvatski (HR) (307.68 KB - PDF)

Amharc

latviešu (LV) (334.28 KB - PDF)

Amharc

Malti (MT) (324.47 KB - PDF)

Amharc

Nederlands (NL) (287.82 KB - PDF)

Amharc

polski (PL) (380.69 KB - PDF)

Amharc

português (PT) (288.12 KB - PDF)

Amharc

română (RO) (482.45 KB - PDF)

Amharc

slovenčina (SK) (324.97 KB - PDF)

Amharc

slovenščina (SL) (318.42 KB - PDF)

Amharc

suomi (FI) (285.73 KB - PDF)

Amharc

svenska (SV) (287.15 KB - PDF)

Amharc

Product information

български (BG) (936.84 KB - PDF)

Amharc

español (ES) (457.64 KB - PDF)

Amharc

čeština (CS) (695.23 KB - PDF)

Amharc

dansk (DA) (443.55 KB - PDF)

Amharc

Deutsch (DE) (456.17 KB - PDF)

Amharc

eesti (ET) (460.88 KB - PDF)

Amharc

ελληνικά (EL) (957.24 KB - PDF)

Amharc

français (FR) (383.63 KB - PDF)

Amharc

hrvatski (HR) (504.46 KB - PDF)

Amharc

italiano (IT) (614.01 KB - PDF)

Amharc

latviešu (LV) (750.12 KB - PDF)

Amharc

lietuvių (LT) (673.01 KB - PDF)

Amharc

magyar (HU) (1.07 MB - PDF)

Amharc

Malti (MT) (774.79 KB - PDF)

Amharc

Nederlands (NL) (445.92 KB - PDF)

Amharc

polski (PL) (1.09 MB - PDF)

Amharc

português (PT) (456.69 KB - PDF)

Amharc

română (RO) (807.04 KB - PDF)

Amharc

slovenčina (SK) (711.68 KB - PDF)

Amharc

slovenščina (SL) (702.28 KB - PDF)

Amharc

suomi (FI) (456.54 KB - PDF)

Amharc

svenska (SV) (441.7 KB - PDF)

Amharc

Íslenska (IS) (622.5 KB - PDF)

Amharc

norsk (NO) (656.3 KB - PDF)

Amharc
Latest procedure affecting product information:IAIN/0014
31/10/2012

български (BG) (299.51 KB - PDF)

Amharc

español (ES) (219.22 KB - PDF)

Amharc

čeština (CS) (262.67 KB - PDF)

Amharc

dansk (DA) (227.42 KB - PDF)

Amharc

Deutsch (DE) (218.75 KB - PDF)

Amharc

eesti (ET) (221.16 KB - PDF)

Amharc

ελληνικά (EL) (268.37 KB - PDF)

Amharc

français (FR) (221.14 KB - PDF)

Amharc

hrvatski (HR) (227.55 KB - PDF)

Amharc

italiano (IT) (191.92 KB - PDF)

Amharc

latviešu (LV) (256.74 KB - PDF)

Amharc

lietuvių (LT) (210.34 KB - PDF)

Amharc

magyar (HU) (210.45 KB - PDF)

Amharc

Malti (MT) (250.85 KB - PDF)

Amharc

Nederlands (NL) (228.06 KB - PDF)

Amharc

polski (PL) (245.92 KB - PDF)

Amharc

português (PT) (231.37 KB - PDF)

Amharc

română (RO) (434.62 KB - PDF)

Amharc

slovenčina (SK) (253.67 KB - PDF)

Amharc

slovenščina (SL) (237.31 KB - PDF)

Amharc

suomi (FI) (204.11 KB - PDF)

Amharc

svenska (SV) (218.51 KB - PDF)

Amharc

Íslenska (IS) (185.95 KB - PDF)

Amharc

norsk (NO) (222.67 KB - PDF)

Amharc

Product details

Name of medicine
Spironolactone Ceva
Active substance
spironolactone
International non-proprietary name (INN) or common name
spironolactone
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QC03DA01

Pharmacotherapeutic group

Diuretics

Therapeutic indication

For use in combination with standard therapy (including diuretic support, where necessary) for the treatment of congestive heart failure caused by valvular regurgitation in dogs.

Authorisation details

EMA product number
EMEA/V/C/000105
Marketing authorisation holder
Ceva Santé Animale

10 avenue de la Ballastière
33500 Libourne
France

Opinion adopted
17/04/2007
Marketing authorisation issued
20/06/2007
Revision
7

Assessment history

This page was last updated on

Share this page